Page last updated: 2024-09-03

butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine and Acute Confusional Senile Dementia

butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine has been researched along with Acute Confusional Senile Dementia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Brandenburg, LO; Brandt, E; Griep, A; Heneka, MT; Kaddatz, H; Kipp, E; Kipp, M; Pufe, T; Putzka, T; Samer, S; Schaffrath, A; Schröder, N; Tauber, SC; Welter, JA; Zhan, J; Ziegler, P1

Other Studies

1 other study(ies) available for butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine and Acute Confusional Senile Dementia

ArticleYear
Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease.
    Journal of neuroinflammation, 2020, Apr-24, Volume: 17, Issue:1

    Topics: Alzheimer Disease; Animals; Brain; Disease Models, Animal; Maze Learning; Mice; Mice, Transgenic; Oligopeptides; Receptors, Formyl Peptide

2020